Illumina Releases Multianalyte Tumor Profiling System
The 170-gene next-generation sequencing solution seeks to support transformation of the tumor-profiling paradigm from a series of single-gene tests to a multianalyte approach.
Read MorePosted by Elaine Sanchez Wilson | Jan 3, 2017 | Cancer, Molecular Diagnostics |
The 170-gene next-generation sequencing solution seeks to support transformation of the tumor-profiling paradigm from a series of single-gene tests to a multianalyte approach.
Read MorePosted by Elaine Sanchez Wilson | Dec 13, 2016 | Company News, Information Technology |
The acquisition expands Sunquest’s solution for molecular pathology laboratories and supports the advancement of precision medicine.
Read MorePosted by Elaine Sanchez Wilson | Dec 6, 2016 | Cancer |
Today’s clinical laboratories operate in an environment of rapid technological change.
Read MorePosted by Elaine Sanchez Wilson | Nov 29, 2016 | Molecular Diagnostics |
Illumina’s contribution includes variants of all classifications, from pathogenic to benign.
Read MorePosted by Elaine Sanchez Wilson | Nov 22, 2016 | Molecular Diagnostics |
Starting from minute and low-cellularity FFPE specimens, two new products now give access to samples that were previously inaccessible for genetic analysis.
Read More